ChristosEmmanouelEmmanouilidesMD

Clinical Trials

• Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation Start of enrollment: 1997 Nov 01

  Completed

  Phase 2

• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation Start of enrollment: 1999 May 01

  Completed

  Phase 2

• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

  Withdrawn

  Phase 1

• Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer Start of enrollment: 2000 Jan 01

  Completed

  Phase 2

• Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease

  Unknown status

  Phase 1, Phase 2

• Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia Start of enrollment: 1999 Dec 01

  Completed

  Phase 2

• Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia Start of enrollment: 2001 Feb 01

  Unknown status

  Phase 2

• Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia Start of enrollment: 2001 Sep 01

  Completed

  Phase 2

• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Start of enrollment: 2002 Mar 01

  Completed

  Phase 1

• Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2002 May 01

  Unknown status

  Phase 2

• Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia Start of enrollment: 2003 Apr 01

  Terminated

  Phase 1

• Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2003 Jun 01

  Completed

  Phase 2

• Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas Start of enrollment: 2008 Jan 01

  Completed

  Phase 1, Phase 2

• Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer Start of enrollment: 2008 Nov 01

  Completed

  Phase 2

• Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma Start of enrollment: 2005 Oct 01

  Terminated

  Phase 2

• Join now to see all